These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7523197)

  • 1. Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A.
    Miyashita T; Yamamoto H; Nishimune Y; Nozaki M; Morita T; Matsushiro A
    FEBS Lett; 1994 Oct; 353(2):225-9. PubMed ID: 7523197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
    Mikkelsen IM; Huseby NE; Visvikis A; Moens U
    Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression within a chromatin domain: the role of core histone hyperacetylation.
    Schlake T; Klehr-Wirth D; Yoshida M; Beppu T; Bode J
    Biochemistry; 1994 Apr; 33(14):4197-206. PubMed ID: 8155635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of differentiation-dependent DNase I-hypersensitive sites in the mouse EndoA gene.
    Miyashita T; Yamamoto H; Takemoto Y; Nozaki M; Morita T; Matsushiro A
    Gene; 1993 Mar; 125(2):151-8. PubMed ID: 7681804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
    Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
    Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression.
    Garcia-Villalba P; Jimenez-Lara AM; Castillo AI; Aranda A
    DNA Cell Biol; 1997 Apr; 16(4):421-31. PubMed ID: 9150429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
    Scott GK; Marden C; Xu F; Kirk L; Benz CC
    Mol Cancer Ther; 2002 Apr; 1(6):385-92. PubMed ID: 12477051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors.
    Kim SY; Woo MS; Kim WK; Choi EC; Henson JW; Kim HS
    J Virol; 2003 Mar; 77(6):3394-401. PubMed ID: 12610114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
    Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
    Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
    Hernández-Oliveras A; Izquierdo-Torres E; Meneses-Morales I; Rodríguez G; Zarain-Herzberg Á; Santiago-García J
    Int J Biochem Cell Biol; 2019 Aug; 113():8-16. PubMed ID: 31146004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
    Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
    Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.
    Chen WY; Bailey EC; McCune SL; Dong JY; Townes TM
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5798-803. PubMed ID: 9159154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
    McBain JA; Eastman A; Nobel CS; Mueller GC
    Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
    Walker GE; Wilson EM; Powell D; Oh Y
    Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase.
    Takahashi I; Miyaji H; Yoshida T; Sato S; Mizukami T
    J Antibiot (Tokyo); 1996 May; 49(5):453-7. PubMed ID: 8682722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation.
    Arts J; Lansink M; Grimbergen J; Toet KH; Kooistra T
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):171-6. PubMed ID: 7646441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter.
    Hodny Z; Li R; Barath P; Nelson BD
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):93-7. PubMed ID: 10657244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
    Gunin AG; Kapitova IN; Suslonova NV
    J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.